About Eribulin Mesylate
Class: | Antineoplastic agent, Microtubule inhibitor
Use: | Treatment of metastatic breast cancer in patients who have received at least two prior therapies for metastatic disease, including an anthracycline and a taxane. Also indicated for the treatment of liposarcoma after prior therapies.
Adult dose: | 1.4 mg/m² administered intravenously over 2 to 5 minutes on days 1 and 8 of a 21-day cycle.
Pediatric dose: | Safety and efficacy have not been established in pediatric patients; not reco
Drug Class
Antineoplastic agent, Microtubule inhibitor
Uses & Indications
Treatment of metastatic breast cancer in patients who have received at least two prior therapies for metastatic disease, including an anthracycline and a taxane. Also indicated for the treatment of liposarcoma after prior therapies.
Storage Requirements
Store at 20°C to 25°C (68°F to 77°F); protect from light; do not freeze. Once diluted, the solution should be used immediately or stored at 2°C to 8°C (36°F to 46°F) for up to 24 hours.
Manufacturer & Packaging
Manufacturer: Eisai Europe Limited, UNITED KINGDOM
Package Size
2ml Vial
Price & Supplier
Price in UAE: AED 2416.00
Dosage Information
Adult Dose
1.4 mg/m² administered intravenously over 2 to 5 minutes on days 1 and 8 of a 21-day cycle.
Pediatric Dose
Safety and efficacy have not been established in pediatric patients; not recommended for use in this population.
Side Effects
Common side effects include fatigue, nausea, neutropenia, peripheral neuropathy, alopecia, constipation, and diarrhea.
Contraindications & Precautions
Hypersensitivity to eribulin or any component of the formulation; patients with severe liver impairment (Child-Pugh Class C).
Important Warnings
Risk of myelosuppression, including neutropenia; monitor complete blood counts regularly. Risk of peripheral neuropathy; assess for symptoms prior to each dose. Use caution in patients with hepatic impairment.
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.